−3.05USD
−116.80 MUSD
30.64 M
About RAPT Therapeutics, Inc.
Sector
CEO
Brian Russell Wong
Headquarters
South San Francisco
Website
Employees (FY)
131
Founded
2015
ISIN
US75382E1091
FIGI
BBG00PGK50M2
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RAPT is 7.95 USD — it has increased by 0.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RAPT Therapeutics, Inc. stocks are traded under the ticker RAPT.
RAPT Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RAPT stock is 4.46% volatile and has beta coefficient of 2.14. Check out the list of the most volatile stocks — is RAPT Therapeutics, Inc. there?
One year price forecast for RAPT Therapeutics, Inc. has a max estimate of 48.00 USD and a min estimate of 10.00 USD.
RAPT earnings for the last quarter are −0.82 USD per share, whereas the estimation was −0.75 USD resulting in a −8.86% surprise. The estimated earnings for the next quarter are −0.86 USD per share. See more details about RAPT Therapeutics, Inc. earnings.
RAPT Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 336.57 K USD. In the next quarter revenue is expected to reach 132.50 K USD.
Yes, you can track RAPT Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
RAPT stock has fallen by 14.24% compared to the previous week, the month change is a 7.77% fall, over the last year RAPT Therapeutics, Inc. has showed a 58.53% decrease.
RAPT net income for the last quarter is −30.88 M USD, while the quarter before that showed −31.37 M USD of net income which accounts for 1.58% change. Track more RAPT Therapeutics, Inc. financial stats to get the full picture.
Today RAPT Therapeutics, Inc. has the market capitalization of 275.95 M, it has increased by 1.34% over the last week.
No, RAPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RAPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAPT Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 131.00 employees. See our rating of the largest employees — is RAPT Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAPT Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAPT Therapeutics, Inc. stock shows the sell signal. See more of RAPT Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on RAPT Therapeutics, Inc. future price: according to them, RAPT price has a max estimate of 48.00 USD and a min estimate of 10.00 USD. Read a more detailed RAPT Therapeutics, Inc. forecast: see what analysts think of RAPT Therapeutics, Inc. and suggest that you do with its stocks.